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Abstract
Background: There are more than 50 genes for autosomal dominant and autosomal recessive
nonsyndromic hereditary deafness that are yet to be cloned. The human genome sequence and
expression profiles of transcripts in the inner ear have aided positional cloning approaches. The
knowledge of protein interactions offers additional advantages in selecting candidate genes within
a mapped region.
Results: We have employed a bioinformatic approach to assemble the genes encoded by genomic
regions that harbor various deafness loci. The genes were then in silico analyzed for their candidacy
by expression pattern and ability to interact with other proteins. Such analyses have narrowed a
list of 2400 genes from suspected regions of the genome to a manageable number of about 140 for
further analysis.
Conclusion: We have established a list of strong candidate genes encoded by the regions linked
to various nonsyndromic hereditary hearing loss phenotypes by using a novel bioinformatic
approach. The candidates presented here provide a starting point for mutational analysis in well-
characterized families along with genetic linkage to refine the loci. The advantages and
shortcomings of this bioinformatic approach are discussed.
Background
Hearing loss, acquired or genetic, is a major worldwide
public health concern. Numerous genes have been linked
to hearing disorders [1]. These disorders may be syndro-
mic or nonsyndromic; conductive, sensorineural, or
mixed; and prelingual or postlingual [2]. The various
genetic forms of hearing loss are distinguished based on
otologic, audiologic and physical examination combined
with linkage analysis. Some representative deafness genes
that have been identified include the Alport syndrome
(COL4A3, COL4A4 or COL4A5 genes), branchio-oto-renal
syndrome (EYA1  gene), Mohr-Tranebjaerg syndrome
(TIMM8A  gene), Pendred syndrome (SLC26A4  gene),
Jervell and Lange-Nielsen Syndrome (KVLQT1 and
KCNE1 genes), Usher syndrome with its several types,
Norrie disease (NDP gene), DFNB1 (GJB2 gene), DFN3
(POU3F4  gene), DFNB4 (SLC26A4  gene), DFNA6/14
(WFS1 gene), and several others [3,4]. The mutational
analysis of genes such as GJB2 (encoding the protein con-
nexin 26) and GJB6 (encoding the protein connexin 30)
[3,5,6] has aided diagnosis and geneticcounselling.
Syndromic hearing loss is associated with a variety of
other clinical findings and is relatively less prevalent. In
contrast, nonsyndromic hearing loss accounts for more
than 70% of deafness cases and involves autosomal as
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well as X or Y -linked deafness phenotypes [7]. The molec-
ular causes of nearly all nonsyndromic hearing loss are
associated with inner ear structural damage, and changes
in both the inner and the middle ear [8]. Mutations in
genes such as the ACTG1,  COCH,  COL11A2,  DFNA5,
EYA4,  GJB2,  GJB6,  KCNQ4,  MYO6,  MYO7A,  TECTA,
TMC1, and WFS1, as well as altered expression of genes
such as GJB3 and MYO1A have been associated with the
autosomal dominant types that are generally progressive
and involve changes in inner ear [9-11]. The autosomal
recessive phenotypes are associated with mutations in
genes such as the CDH23, CLDN14, ESPN, GJB2, GJB6,
MYO15A,  MYO6,  MYO7A,  OTOF,  PCDH15,  SLC26A4,
STRC, TECTA, TMC1, TMIE, TMPRSS3, and USH1C, as
well as altered expression of GJB3 [8].
The map locations of a large number of nonsyndromic
autosomal recessive deafness phenotypes are known, but
the specific genes responsible for all these phenotypes
have not been identified [4]. The cloning of genes
involved in such phenotypes requires refinement of the
suspected genomic interval to as short a region as possible
by linkage analysis. However, it is not always possible to
map a gene within an interval that is amenable for muta-
tion analysis. The mutation analysis of all genes encoded
by a large genomic interval is extremely labor-intensive.
We describe here a bioinformatic approach that can
reduce the candidate genes to a manageable number for
mutation analysis. Initially, all the genes from a particular
locus are cross-referenced to the databases of expressed
mouse inner ear genes and the expressed human cochlear
genes. The alternative procedure included a search for
interacting proteins for the gene products mapping to the
candidate region. As presented here, this approach has led
to a set of specific candidate genes.
Results and discussion
The locations of 23 autosomal dominant and 27 auto-
somal recessive nonsyndromic deafness phenotypes
mapped to several chromosomes downloaded from
hereditary hearing loss homepage are shown in Tables 1
and 2[4]. Additional loci for nonsyndromic conditions
are mapped to chromosomes 1, 8, X and Y [4]. The hered-
itary hearing loss homepage is updated on a regular basis.
The marker boundaries of these locations encompass
between 1.4 and 18.6 million basepairs (Mbp) for various
loci. To generate a set of candidate genes for the listed loci,
a strategy schematically represented in Figure 1 was fol-
lowed. The determination of coding sequences and/or
genes in a genomic region was made by Unigene [12].
However, the genes encoded in a large genomic interval
are too many to be characterized by mutational analysis in
a gene-by-gene approach. Therefore, we used the human
cochlea and mouse inner ear expression databases [13,14]
to eliminate from the candidate list certain genes that
were not expressed in these organs. Such in silico expres-
sion analysis relies on the assumption that the expression
databases are comprehensive. However, the characteriza-
tion of all transcripts expressed in the ear is far from com-
plete. We, therefore, introduced another step in our
candidate gene strategy by taking advantage of the human
protein reference database (HPRD) and generated a list of
interacting genes for every gene mapping to candidate
deafness loci [15]. The rationale for protein interaction is
as follows. If a gene encoded in the candidate region inter-
acts with a gene that is either involved in inner ear devel-
opment/function, or a protein shows interaction with
more than one candidate genes mapping to different loci,
then such a gene is likely to be involved in the phenotype
in question. The interaction pattern of the gene products
from Usher syndrome is a good example to illustrate this
point. The known gene products for several Usher syn-
drome loci are known to form interactions in vivo [16].
The mutation of each one of these genes affects protein
interactions and influences Usher type 1 phenotype [17].
The five forms of Usher syndrome have defects in myosin
VIIA, harmonin, cadherin 23, protocadherin 15, and a
putative scaffolding protein sans. Harmonin binds sans,
and it also binds myosin VIIA and protocadherin 15 [34].
The role of cadherins in mediating cell-cell interaction is
well-characterized. Furthermore, interactions of har-
monin (USH1C) with USH2A, USH2C and USH2B are
mediated by PDZ domains [35,36]. In retrospect, if the
interacting protein strategy had been used to select candi-
date genes for Usher syndrome subtypes, it is likely that
several genes could have been eliminated from considera-
tion. Therefore, it is reasonable to assume that physical
interactions will exist between proteins that are involved
in inner ear developmental pathway or inner ear signal
transduction pathways, and mutations in any one protein
of the pathway is likely to give the same altered pheno-
type. If proteins of interacting networks can be identified
or predicted, then such genes are natural candidates for a
given phenotype. The above hypothesis is the underlying
rationale for incorporating interacting proteins as a crite-
rion for selecting candidate genes presented in this paper.
Briefly, the strategy is as follows. First, assemble the genes
encoded in all candidate intervals, list the proteins that
interact with genes in the candidate region, and then
search for candidates on different loci that interact with a
common protein. Such a criterion will fulfil the rationale
of putative involvement of proteins at two different loci
involved in a common biological process, and by associa-
tion the respective genes mapping to two different loci
will be considered as candidates.
The application of candidate gene isolation is demon-
strated for the autosomal dominant condition DFNA27.
The gene is mapped to the genomic interval 4q12 span-
ning 15 Mbp [4]. This region codes for 36 known and 30BMC Genomics 2006, 7:180 http://www.biomedcentral.com/1471-2164/7/180
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hypothetical proteins (Table 3) [18]. The comparison of
these genes to expression databases reduced the list to 10
genes from the human cochlear database and three found
in the mouse inner ear (Table 4) [13,14,19]. The possibil-
ity remained for the elimination of a stronger candidate
just on the basis that it did not score a hit in expression
databases. To avoid such an error, we have assembled lists
of interacting proteins by using the human protein refer-
ence database (HPRD) [15] for every gene identified by
GeneRetriever® from the candidate region. If an interactor
of a gene in the candidate interval is expressed in inner ear
then the gene is considered a candidate. Alternatively, the
interacting genes from a specific locus list were compared
against lists from other loci to identify if a hit was scored
against proteins among two or more lists. The original
genes corresponding to such interactor(s) were consid-
ered as candidates for the respective deafness loci. The
strong candidates, based on the above analyses, for vari-
ous deafness loci are presented in Table 5.
In principle, the interactions-based strategy can be tar-
geted to identify candidates for deafness if a database for
interacting proteins involved in inner ear development
and function is available. For example, oncomodulin and
prestin are expressed in outer hair cells [20]. The protein
interaction approach could link the possible candidate
genes to specific cochlear cells by identifying known inter-
actants. If the interactors happen to map to a region har-
boring a deafness gene, such interactors are obvious
candidates for mutational analysis. However, such an
approach will require identification of interacting pro-
teins. The primary limitation of the in silico approach
described here is inadequate description of interacting
protein networks.
The strong candidate list includes genes such as various
cadherins, collagens, some cytoskeletal components and a
number of growth factors and inner ear specific tran-
scripts. For example, HAT (Human airway trypsin-like
protease) from the DFNA27 locus is known to enhance
cell growth and IL-8 production. It has been implicated in
induction of PAR-2 (protease activated receptor)-medi-
ated IL-8 release in psoriasis vulgaris [21]. Because HAT is
expressed in the ear, and protease activated receptor (PAR-
2) has the ability to activate G-proteins followed by an
increase in calcium ion concentration, we consider HAT as
a candidate. KDR(kinase insert domain receptor), a vascu-
lar endothelial growth factor(VEGF) receptor-type 2, from
the same locus shows age-dependent expression in the
inner ear [22]. Our analyses indicated that only a fraction
(200/2400) of genes mapping to various genomic inter-
vals was expressed in the inner ear. We attribute these
observations to depth of inner ear libraries. It is likely that
the genes being scored in these libraries have multiplicity
for certain transcripts and absence of other transcripts. For
example, out of 153 genes at the DFNA7 locus, only 18
genes are present in the cochlear library. We cannot rea-
sonably rule out the expression of the remaining 135
Table 1: Autosomal dominant nonsyndromic loci.
Locus Name Location
DFNA7 1q21–q23
DFNA16 2q24
DFNA18 3q22
DFNA21 6p21
DFNA23 14q21–q22
DFNA24 4q
DFNA25 12q21–24
DFNA27 4q12
DFNA30 15q25–26
DFNA31 6p21.3
DFNA32 11p15
DFNA34 1q44
DFNA37 1p21
DFNA41 12q24–qter
DFNA42 5q31.1–32
DFNA43 2p12
DFNA44 3q28–29
DFNA47 9p21–22
DFNA49 1q21–q23
DFNA50 7q32
DFNA53 14q11–q12
DFNA54 5q31
Table 2: Autosomal recessive nonsyndromic loci.
Locus Name Location
DFNB5 14q12
DFNB13 7q34–36
DFNB14 7q31
DFNB15 3q21–q25, 19p13
DFNB17 7q31
DFNB19 18p11
DFNB20 11q25–qter
DFNB24 11q23
DFNB25 4p15.3–q12
DFNB26 4q31
DFNB27 2q23–q31
DFNB28 22q13
DFNB32 1p13.3–22.1
DFNB33 9q34.3
DFNB35 14q24.1–24.3
DFNB38 6q26–q27
DFNB39 7q11.22–q21.12
DFNB40 22q
DFNB42 3q13.31–q22.3
DFNB44 7p14.1–q11.22
DFNB46 18p11.32–p11.31
DFNB48 15q23–q25.1
DFNB49 5q12.3–q14.1.
DFNB55 4q12–q13.2
DFNB58 2q14.1–q21.2
DFNB60 5q22–q31BMC Genomics 2006, 7:180 http://www.biomedcentral.com/1471-2164/7/180
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genes in the inner ear. Therefore, the approach presented
here will be more comprehensive if we do not include ear
expression in this scheme. Consequently, in a second
attempt to mine the protein-interaction data obtained
from the HRPD, we analyzed all genes encoded in the can-
didate intervals for their interactors. The interaction data
were considerably exhaustive and resulted in many more
possible candidates with their expression not reported in
the ear expression library. A summary of gene numbers at
different loci before and after interacting proteins analysis
using the ear-expression scheme is presented in Table 6.
The mouse syntenic genes are also indicated in these
results. The number of unfiltered candidate genes for each
locus obtained by interacting proteins analysis is shown
in Table 7. To elucidate the relevance of genes not found
in the ear-expression library as possible candidates, we
performed a literature search cross-referencing the identi-
fied gene with any reported hearing-associated condition
in humans or other model animals. Some of these genes
were linked to ear-development or hearing impairment as
a secondary or unrelated symptom of other conditions.
For example, Neurod1 gene mapping to DFNB27 locus
was not reported in any of the inner ear libraries. How-
ever, it appears to participate in the development of the
auditory system as NeuroD1 null mice exhibited severe
reduction of sensory neurons in the cochlear-vestibular
ganglion [23]. E2F3, a transcription factor of the E2F fam-
ily mapping to the DFNA21 locus, may be indirectly
implicated by its ability to regulate cell proliferation pos-
sibly during the developmental stages [24]. Other candi-
date genes from the unfiltered candidate analysis for the
various loci are listed in Table 8. Thus the unfiltered strat-
egy adds 51 candidates for 25 loci and expands the candi-
date list to 92 genes for further mutation analysis.
Our approach indicated the presence of possible candi-
dates within most of the mapped loci. However, predic-
tion of candidate genes was not easy for loci indicated by
asterisks in Table 7, because the genes mapping to these
loci did not fulfil the criteria we have employed. We fur-
ther examined these genes on the basis of their reported
function. The following description pertains to specific
genes that are not indicated in the candidate lists. Within
the DFNA16 locus, SCNA3 and SCNA2, both being volt-
age-gated sodium channels, can be considered candidates
based on involvement of related sodium channels in hear-
ing [25]. Similarly, ATP2C1 in DFNA18 locus is a likely
candidate because mutations in a related ATPase have
been shown in mice that are profoundly deaf and have a
balance defect [26]. The EphB1 gene, within the DFNA18
locus, plays a major role during the development of the
inner ear in mice [27]. The DFNA23 locus has six1 gene
that plays a pivotal role in the control of the mouse otic
vesicle patterning [28]. Neugrin, mapping to DFNA30
locus, appeared to be an appropriate candidate as it was
shown to be up-regulated throughout neuronal differenti-
ation [29]. A possible candidate for the DFNA47 locus is
the transcription factor Nfib, an essential player in the
maturation of lungs and brain development [30]. The
splicing regulation carried out by Pnn, mapping to the
DFNB5 region, is a reasonable candidate [31]. We believe
the genes presented in this article may serve as starting
candidates toward identifying molecular mechanisms for
specific deafness phenotypes.
Conclusion
We have used an in silico strategy to assemble a list of can-
didate genes that are positionally linked to and could be
causing specific nonsyndromic hereditary hearing loss
conditions. As presented here, a list of 2378 genes map-
ping to various genomic intervals have been narrowed
down to 92 genes as candidates. These candidates may be
analyzed for mutations in various deafness phenotypes in
parallel with attempts to further narrow down the sus-
pected region by genetic linkage analysis. It warrants men-
tion that the potential of the approach presented here will
be better harnessed as more information becomes availa-
ble about inner ear transcripts and protein interaction net-
works.
Methods
Generating list of loci for in silico prediction
The list of most current information and identified loci for
the various nonsyndromic hearing loss and syndromic
forms was obtained from the Hereditary Hearing Loss
Homepage and the survey of latest literature [4]. The list
of deafness loci with unknown specific genes for the auto-
Schematic flow for information processing to predict candi- date genes Figure 1
Schematic flow for information processing to predict candi-
date genes. The rectangles contain tasks that were processed 
in the sequence as indicated by arrows.BMC Genomics 2006, 7:180 http://www.biomedcentral.com/1471-2164/7/180
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somal dominant, autosomal recessive, and syndromic
forms was also compiled from the same web based source.
GeneRetriever for EST identification within each deafness 
locus
A list of all cloned and identified genes from within each
of the listed genomic intervals was obtained using GeneR-
etriever®, a Perl-based data mining software that has a sim-
ple graphical user interfaces [12]. It automatically retrieves
from either NCBI or Ensembl databases information that
includes all genes and transcripts located in a genomic
interval flanked by two genetic markers.
Database analysis
The list of genes and transcripts for each specific locus
obtained using GeneRetriever® was compared against two
sets of ear gene-expression databases. The first set includes
genes expressed in the developing ear [13]. This list is a
compilation of the numerous genes that are expressed at
different stages during inner ear development in two ani-
mal species. The second set was obtained from fetal coch-
lear cDNA library and EST database (updated as of 2002)
of the Morton Hearing Research Group [14]. The data
present in this set was adapted from Unigene [12]. The
database has 14,805 ESTs, and 12,624 ESTs are sorted by
Table 3: GeneRetriever list of known genes found within the DFNA27 locus.
Gene ID Gene Entrez Type GeneDescription Expressed in Cochlear 
Library
Interactor Cochlear 
Protein
KDR 3791 Known kinase insert domain receptor (a type III receptor tyrosine 
kinase)
Yes VEGF A, Grb2, CDH5
FLJ13352 79644 Known hypothetical protein FLJ13352 No
TPARL 55858 Known TPA regulated locus Yes
CLOCK 9575 Known clock homolog (mouse) No
PDCL2 132954 Known phosducin-like 2 No
NMU 10874 Known neuromedin U Yes
SEC3L1 55763 Known SEC3-like 1 (S. cerevisiae) No
KIAA0635 9662 Known KIAA0635 Yes
KIAA1211 57482 Known KIAA1211 protein No
MRPL22P1 359738 Known mitochondrial ribosomal protein L22 pseudogene 1 No
NRPS998 132949 Known 2-aminoadipic 6-semialdehyde dehydrogenase No
PPAT 5471 Known phosphoribosyl pyrophosphate amidotransferase Yes
PAICS 10606 Known phosphoribosylaminoimidazole carboxylase, 
succinocarboxamide synthetase
No
SRP72 6731 Known signal recognition particle 72kDa No* Caspase 3
ARL9 132946 Known ADP-ribosylation factor-like 9 No
GLDCP 2732 Known glycine dehydrogenase (decarboxylase) pseudogene No
HOP 84525 Known homeodomain-only protein Yes HDAC2
SPINK2 6691 Known serine protease inhibitor, Kazal type 2 (acrosin-trypsin 
inhibitor)
No
REST 5978 Known RE1-silencing transcription factor Yes
C4orf14 84273 Known chromosome 4 open reading frame 14 No
POLR2B 5431 Known polymerase (RNA) II (DNA directed) polypeptide B, 
140kDa
Yes
IGFBP7 3490 Known insulin-like growth factor binding protein 7 No* VEGF A, IGF1
SRIL 6644 Known sorcin-like No
LPHN3 23284 Known latrophilin 3 No
EPHA5 2044 Known EphA5 No
CENPC1 1060 Known centromere protein C 1 No
BRDG1 26228 Known BCR downstream signaling 1 No* KIT
FLJ10808 55236 Known hypothetical protein FLJ10808 Yes
GNRHR 2798 Known gonadotropin-releasing hormone receptor No
HAT 9407 Known airway trypsin-like protease Yes PAR-2
FLJ16046 389208 Known FLJ16046 protein No
YT521 91746 Known splicing factor YT521-B No* KHDRBS3, FYN
DESC1 28983 Known DESC1 protein No
UGT2B17 7367 Known UDP glycosyltransferase 2 family, polypeptide B17 No
*These genes are not listed in the human cochlear database. However, their interactors are present in the cochlear database.BMC Genomics 2006, 7:180 http://www.biomedcentral.com/1471-2164/7/180
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Unigene into 4,519 independent clusters. Unigene did
not classify the remaining ESTs due to factors such as pos-
sible contaminating sequences, very small inserts, or
excessive repetitive elements. For a gene within a particu-
lar locus to be considered for candidacy, it has to be
present in either of the above two databases. Genes that
were not present in either expression databases were ini-
tially eliminated from consideration. It warrants mention
that functional significance of expressed sequences in
human and mouse inner ear has been used to propose
deafness candidates [32,33].
Human reference protein database
In comparing the two sets of databases to the list of genes
and transcripts within each hereditary hearing loss locus
obtained using GeneRetriever®, we were able to compile a
Table 5: List of candidates for various deafness loci.
Loci Location Candidates Loci Location Candidates
DFNA7 1q21–q23 ATP1B1 DFNB5 14q12 **
F5 DFNB13 7q34–36 SLC37A3
MYOC DFNB17 7q31 WNT2
SLC19A2 DFNB19 18p11 LAMA1
POU2F1 DFNB20 11q25–qter KCNJ1
DFNA16 2q24 * TECTA
DFNA18 3q22 ** SLC37A2
DFNA21 6p21 * DFNB27 2q23–q31 ITGA6
DFNA23 14q21–q22 ** SP3
DFNA25 12q21–24 HAL DFNB28 22q13 KCNJ4
SLC25A3 MT
IGF1 SOX10
DFNA27 4q12 HAT DFNB32 1p13.3–22.1 COL11A1
KDR/VEGFR2 DR1
DFNA30 15q25–26 ** F3
DFNA31 6p21.3 TNF DFNB33 9q34.3 TUBB2
POU5F1 SLC34A3
DFNA34 1q44 ** DFNB35 14q24.1–24.3 NUMB
DFNA42 5q31.1 FGF1 FOS
GFRA3 DFNB38 6q26–q27 QK1
IK DFNB39 7q11.22–q21.12 POR
PCDH1 DFNB40 22q CRYBB2
DIAPH1 SLC25A1
POU4F3 TBX1
DFNA47 9p21–22 **
*The chromosomal regions for DFNA16 and DFNA21 code for 7 and 9 genes, respectively. However, none of these genes were listed in the 
mouse or human inner ear databases. The candidates as described in the text are based on their functional significance.
**The chromosomal regions for DFNA18, DFNA23, DFNA30, DFNA34, DFNA47 and DFNB5 code for a substantial number of genes. A small 
fraction of these genes are listed in human and mouse inner ear databases as shown in Table 6. Furthermore, no hits were scored by the protein 
interaction approach. Therefore the genes scoring hits in the ear databases may be considered as candidates and prioritized based on their function. 
Some of these priority candidates are described in the text.
Table 4: Cochlear-expressed EST found within DFNA27 locus.
Locus Location Genes from Cochlea Genes from Mouse Genes from Known 
Disorders
DFNA27 4q12 FLJ10808 EPHA5 None
HAT HAT
HOP KDR
KIAA0635
KDR
NMU
POLR2B
PPAT
REST
TPARLBMC Genomics 2006, 7:180 http://www.biomedcentral.com/1471-2164/7/180
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Table 6: Summary of gene numbers from expression-library filtered analysis.
Condition Map Location Interval Number of 
Genes
Mouse 
Synteny/
Chromo #
Mouse 
Genes
Human 
Cochlear 
Genes
Mouse 
Inner ear 
Genes
Interacting 
Proteins
Shared 
Interactors
DFNA7 1q21–q23 18.6 Mb 153 1 161 18 6 15 5
D F N A 1 6 2 q 2 42 . 6  M b72 1 6 0000
DFNA18 3q22 12 Mb 116 6, 9 111 18 4 9 1
D F N A 2 1 6 p 2 13 . 5  M b9 1 0 4 8 0000
D F N A 2 3 1 4 q 2 1 – q 2 2 8  M b 7 9 1 2 6 0 7140
DFNA25 12q21–24 14 Mb 108 10, 5 102 17 2 11 3
DFNA27 4q12 15 Mb 71 5 97 10 3 7 2
D F N A 3 0 1 5 q 2 5 – 2 6 7  M b 7 4 7 5 8 6120
DFNA31 6p21.3 7.5 Mb 304 13, 17 385 13 1 8 2
D F N A 3 4 1 q 4 45  M b 8 8 1 2 3 3010
DFNA42 5q31 12 Mb 176 13, 18 153 21 5 16 6
D F N A 4 7 9 p 2 1 – 2 2 9  M b 6 5 4 7 9 6130
D F N B 5 1 4 q 1 2 5 . 5  M b 1 8 1 2 3 7 2020
D F N B 1 3 7 q 3 4 – 3 6 1 . 4  M b 1 4 6 1 5 1021
D F N B 1 7 7 q 3 16 . 5  M b 2 6 6 4 3 3121
D F N B 1 9 1 8 p 1 1 2 . 8  M b 1 3 1 7 1 1 1111
DFNB20 11q25–qter 13.4 Mb 152 9 263 14 1 6 3
DFNB27 2q23–q31 11 Mb 79 2 95 14 3 3 2
DFNB28 22q13 6.5 Mb 146 15 154 15 5 7 3
DFNB32 1p13.3–22.1 16 Mb 74 3, 5 89 13 3 3 3
D F N B 3 3 9 q 3 4 . 3 3  M b 8 6 2 5 4 3422
D F N B 3 5 1 4 q 2 4 . 1 – 2 4 . 3 8 . 2  M b 1 1 6 1 2 1 0 3 8432
D F N B 3 8 6 q 2 6 – q 2 7 3 . 4  M b5 1 7 31011
DFNB39 7q11.22–q21.12 18 Mb 114 5 108 10 2 2 0
DFNB40 22q11.21–12.1 9 Mb 285 5, 10, 16 76 10 4 4 3
Total 2378 2344 214 52 114 41BMC Genomics 2006, 7:180 http://www.biomedcentral.com/1471-2164/7/180
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Table 7: Summary of gene numbers from unfiltered analysis.
Condition Map Location Interval Number of Genes Interacting Proteins
DFNA7 1q21–q23 18.6 Mb 153 29
DFNA16 2q24 2.6 Mb 7 1
DFNA18 3q22 12 Mb 116 21
DFNA21 6p21 3.5 Mb 9 3
DFNA23 14q21–q22 8 Mb 79 29
DFNA25 12q21–24 14 Mb 108 33
DFNA27 4q12 15 Mb 71 9
DFNA30 15q25–26 7 Mb 74 18
DFNA31 6p21.3 7.5 Mb 304 48
DFNA34 1q44 5 Mb 88 19
DFNA42 5q31 12 Mb 176 48
DFNA47 9p21–22 9 Mb 65 19
DFNB5 14q12 5.5 Mb 18 5
DFNB13 7q34–36 1.4 Mb 14 6
DFNB17 7q31 6.5 Mb 26 9
DFNB19 18p11 2.8 Mb 13 3
DFNB20 11q25–qter 13.4 Mb 152 24
DFNB27 2q23–q31 11 Mb 79 12
DFNB28 22q13 6.5 Mb 146 27
DFNB32 1p13.3–22.1 16 Mb 74 11
DFNB33 9q34.3 3 Mb 86 8
DFNB35 14q24.1–24.3 8.2 Mb 116 19
DFNB38 6q26–q27 3.4 Mb 5 1
DFNB39 7q11.22–q21.12 18 Mb 114 12
DFNB40 22q11.21–12.1 9 Mb 285 25
Total 2378 439BMC Genomics 2006, 7:180 http://www.biomedcentral.com/1471-2164/7/180
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list of possible candidate genes for the various loci. To fur-
ther narrow-down and refine this list, we obtained a list of
all known interacting genes for each of the known and
candidate genes using the Human Reference Protein Data-
base (HRPD)[15]. The interacting proteins for all the
genes within the mapped loci were obtained regardless of
whether the gene is present in the two data sets of inner-
ear expressed transcripts. In our first attempt of mining
the data, if a gene is not present in the data set but its inter-
acting proteins are expressed or present in the cochlea or
identified in the table of gene expression in the develop-
ing ear, then this gene is considered a candidate. In our
second attempt, we removed the ear-expression filter
requirement. Therefore, any interacting and repeating
protein was given consideration. Identifying candidate
interacting genes that repeat in many loci supported their
candidacy, resulting in a more comprehensive candidate
list.
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